Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BRD4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
BRD4 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with Aging, Als, Cancer. Connected to 105 entities in the SciDEX knowledge graph.
| Gene Symbol | BRD4 |
| Full Name | Bromodomain-Containing Protein 4 |
| Chromosome | 19p13.12 |
| Target Class | Epigenetic Regulator |
| Function | encodes a member of the bromodomain and extra-terminal domain (BET) protein family that functions as an epigenetic reader of acetylated histones and a master regulator of transcriptional elongation. |
| Mechanism of Action | BRD4 inhibition reduces neuroinflammatory super-enhancer activity while biased BRD4 modulators can selectively restore neuroprotective gene expression |
| Druggability | High (0.73) |
| Pathways | NF-κB |
| UniProt ID | [O60885](https://www.uniprot.org/uniprot/O60885) |
| Ensembl ID | ENSG00000141867 |
| GeneCards | BRD4 |
| Human Protein Atlas | BRD4 |
| Inflammatory gene activation | BRD4 is recruited to NF-κB-responsive promoters during inflammation, serving as a co-activator for pro-inflammatory transcription |
| Bookmarking during mitosis | BRD4 remains bound to acetylated chromatin during mitosis, "bookmarking" active genes for rapid reactivation after cell division |
| Phase separation | BRD4 undergoes liquid-liquid phase separation to form transcriptional condensates at super-enhancers, concentrating transcriptional machinery |
| Associated Diseases | ALS, INFLAMMATION, Lymphoma, Tumor, multiple sclerosis, neurodegeneration |
| Known Drugs/Compounds | JQ1 |
| Interactions | TNF, APOE, MYC, PI3K, IGF2BP2, Rb |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | Chromatin Accessibility Restoration via BRD4 Modul |
| KG Connections | 394 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
BRD4["<b>BRD4</b>"]
H3K9["H3K9"]
BRD4 -->|"modifies"| H3K9
chromatin_remodeling(["chromatin_remodeling"])
BRD4 -->|"regulates"| chromatin_remodeling
neurodegeneration{"neurodegeneration"}
BRD4 -->|"therapeutic target"| neurodegeneration
Als{"Als"}
BRD4 -->|"therapeutic target"| Als
Aging{"Aging"}
BRD4 -->|"therapeutic target"| Aging
Ms{"Ms"}
BRD4 -->|"therapeutic target"| Ms
BRD4 -->|"activates"| Als
Hepatitis{"Hepatitis"}
BRD4 -->|"activates"| Hepatitis
BRD4 -->|"activates"| Ms
Lymphoma{"Lymphoma"}
BRD4 -->|"associated with"| Lymphoma
BRD4 -->|"biomarker for"| Ms
Tumor{"Tumor"}
BRD4 -->|"associated with"| Tumor
h_addc0a61["h-addc0a61"]
h_addc0a61 -->|"therapeutic target"| BRD4
NSD3_short["NSD3-short"]
NSD3_short -->|"binds"| BRD4
SNORA28["SNORA28"]
SNORA28 -->|"interacts with"| BRD4
h_addc0a61 -->|"targets"| BRD4
AMPK["AMPK"]
AMPK -->|"associated with"| BRD4
MITOPHAGY["MITOPHAGY"]
MITOPHAGY -->|"activates"| BRD4
FOXO3["FOXO3"]
FOXO3 -->|"associated with"| BRD4
ULK1["ULK1"]
ULK1 -->|"associated with"| BRD4
AUTOPHAGY["AUTOPHAGY"]
AUTOPHAGY -->|"associated with"| BRD4
MTORC1["MTORC1"]
MTORC1 -->|"associated with"| BRD4
PYROPTOSIS["PYROPTOSIS"]
PYROPTOSIS -->|"activates"| BRD4
VDAC1["VDAC1"]
VDAC1 -->|"inhibits"| BRD4
style BRD4 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | inhibits | disease | 0.85 |
| H3K9 | modifies | protein | 0.80 |
| IGF2BP2 | regulates | gene | 0.80 |
| DLBCL | biomarker_for | disease | 0.80 |
| neural stem cells | inhibits | cell_type | 0.80 |
| neural stem cells | regulates | cell_type | 0.80 |
| Als | therapeutic_target | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Tumor | inhibits | disease | 0.75 |
| chromatin_remodeling | regulates | pathway | 0.70 |
| DLG4 | regulates | gene | 0.70 |
| SYNAPTIC TRANSMISSION | regulates | phenotype | 0.70 |
| nucleus accumbens | expressed_in | brain_region | 0.70 |
| Epigenetic | activates | pathway | 0.70 |
| APOPTOSIS | inhibits | gene | 0.70 |
| Apoptosis | inhibits | pathway | 0.70 |
| NEURODEGENERATION | treats | phenotype | 0.70 |
| NEURODEGENERATION | activates | phenotype | 0.70 |
| NEURODEGENERATION | inhibits | phenotype | 0.70 |
| INFLAMMATION | interacts_with | phenotype | 0.70 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.70 |
| NEURONS | regulates | cell_type | 0.70 |
| PHAGOCYTOSIS | treats | phenotype | 0.70 |
| neural stem cells | activates | cell_type | 0.70 |
| neurodegeneration | therapeutic_target | disease | 0.66 |
| DRUG RESISTANCE | targets | phenotype | 0.65 |
| DRUG RESISTANCE | inhibits | phenotype | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Lymphoma | associated_with | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Leukemia | activates | disease | 0.65 |
| Glioblastoma | therapeutic_target | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NSD3-short | binds | entity | 0.90 |
| JQ1 | targets | drug | 0.90 |
| h-addc0a61 | targets_gene | hypothesis | 0.90 |
| SPOP | degrades | protein | 0.85 |
| SNORA28 | interacts_with | gene | 0.80 |
| h-addc0a61 | targets | hypothesis | 0.80 |
| SIRT1 | causes | gene | 0.70 |
| SIRT1 | activates | gene | 0.70 |
| DEPRESSION | interacts_with | disease | 0.70 |
| P300 | activates | gene | 0.65 |
| APOE | targets | gene | 0.65 |
| HEPATOCYTES | activates | cell_type | 0.65 |
| HEPATOCYTES | targets | cell_type | 0.65 |
| FIBROSIS | targets | disease | 0.65 |
| FOXO3 | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| VDAC1 | inhibits | gene | 0.60 |
| GSDMD | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| MTOR | biomarker_for | gene | 0.60 |
| SOX2 | activates | gene | 0.60 |
| LIFR | activates | gene | 0.60 |
| LIF | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| EP300 | activates | gene | 0.60 |
| SMAD3 | activates | gene | 0.60 |
| IGF2BP2 | inhibits | gene | 0.60 |
| ATM | biomarker_for | gene | 0.60 |
| TFEB | causes | gene | 0.60 |
| PRDX1 | biomarker_for | gene | 0.60 |
| IGF2BP2 | encodes | gene | 0.60 |
| SMC1A | associated_with | gene | 0.60 |
| ANKRD11 | contributes_to | gene | 0.60 |
| NIPBL | associated_with | gene | 0.60 |
| HDAC8 | associated_with | gene | 0.60 |
| SMC3 | associated_with | gene | 0.60 |
| ACO1 | biomarker_for | gene | 0.60 |
| BRD2 | activates | gene | 0.60 |
| BRD3 | activates | gene | 0.60 |
| AR | inhibits | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| MTORC1 | associated_with | gene | 0.60 |
| PYROPTOSIS | activates | gene | 0.60 |
| IL-6 | inhibits | gene | 0.60 |
| FERROPTOSIS | associated_with | gene | 0.60 |
| SRXN1 | biomarker_for | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Chromatin Accessibility Restoration via BRD4 Modulation | 0.559 | neurodegeneration | Epigenetic reprogramming in aging neuron |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.670
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Sertad4 Regulates Pathological Cardiac Remodeling. [PMID:41889836] | Francois A, Bermeo-Blanco O, Nguyen BT, | bioRxiv : the preprint server | 2026 | 0 |
| Hsp70-Targeting Chimeras Enable Dual Proteasomal and Lysosomal Degradation of In [PMID:41874277] | Wang Z, Li P, Yin F, Zhang H, Wang S, Te | Journal of medicinal chemistry | 2026 | 0 |
| Cartilage targeting hydrogel nanoplatform degrades BRD4 to alleviate osteoarthri [PMID:41904167] | Zhao Q, Xu T, Du Z, Lu X, Zhang Y, Peng | Nature communications | 2026 | 0 |
| Semi-rigid linkers improve the pharmacokinetic properties and therapeutic effica [PMID:41687266] | Yu S, Hu S, Wang W, Pan C, Zhang H et al | Eur J Med Chem | 2026 | 0 |
| Molecular insights for the tumor suppressor role of SPOP in prostate cancer. [PMID:41707797] | Yan P, Xue X, Hou T, Wang J, Jiang W et | Biochim Biophys Acta Rev Cance | 2026 | 0 |
| Nutrient-driven histone acetylation underlies energy storage and mobilization. [PMID:41786244] | Chen L, Zhu L, Xiao H, Wang X, Xia F et | Mol Metab | 2026 | 0 |
| D-MBIS Nonbonded Force Field Parameters Improve Specificity and Selectivity Pred [PMID:41849667] | Macaya L, Vöhringer-Martinez E | J Phys Chem B | 2026 | 0 |
| BRD4 directs myofiber identity and metabolic adaptation through CHD4 cooperation [PMID:41957025] | Zhou Z, Liu L, Xu Z, Zhou D, Liu A et al | Nat Commun | 2026 | 0 |
| Harnessing FBXO31 with Terminal Amide-Functionalized Molecules for Targeted Prot [PMID:41963263] | Zhang C, Jin X, Zhou C, Jenkins MJ, Riha | J Am Chem Soc | 2026 | 0 |
| Designing an Osmium(II) Complex to Inhibit the Growth and Recurrence of Tumors b [PMID:41964570] | Zhu M, Jiang M, Liao W, Qi K, Li G et al | J Med Chem | 2026 | 0 |
| Design, synthesis and evaluation of novel BRD4 and RIPK3 dual inhibitors as pote [PMID:41966492] | Moukha-Chafiq O, Yatchang MF, Houghtling | Bioorg Med Chem Lett | 2026 | 0 |
| Alkyne Two-Phase Strategy: Rapid Generation of TK-285-Derived PROTACs as BRD4 De [PMID:41852276] | Yamakoshi H, Watanabe R, Segawa R, Ishih | Journal of medicinal chemistry | 2026 | 0 |
| The epigenetic and epitranscriptomic regulation of Brd4-Mettl3 axis on STING med [PMID:41917296] | Zhao J, Luo X, Wang Z, Luo W, Wu S, Ma X | Inflammation research : offici | 2026 | 0 |
| Punicalagin with anti-inflammatory activities affects Brd-4 mediated chromatin r [PMID:41807492] | Li H, Li Q, Wan T, Wang Y, Zhang S | Scientific reports | 2026 | 0 |
| Targeting BRD4-A Promising Therapeutic Option for Glioblastoma? [PMID:41828493] | Lindner M, Lisińska D, Kędzierzyńska A, | International journal of molec | 2026 | 0 |
| High-intensity interval training alleviates COPD-induced gastrocnemius muscle dy [PMID:41865095] | Zhu C, Peng W, Yang L, Zhang W | Journal of muscle research and | 2026 | 0 |
| A photothermal immune hydrogel dressing for enhanced post-melanoma resection tre [PMID:41877232] | Tan D, Zhu W, Liu S, Liao F, Xu X, Luo J | Journal of nanobiotechnology | 2026 | 0 |
| Recovery of FAM134A-mediated ER-phagy through BRD4 inhibition alleviates ethanol [PMID:40959274] | ["Lim J", "Chae C", "Yoon J", "Cho J", " | International journal of biolo | 2025 | 0 |
| A human Tau expressing zebrafish model of progressive supranuclear palsy identif [PMID:39294122] | ["Bai Q", "Shao E", "Ma D", "Jiao B", "S | Nature communications | 2024 | 0 |
| Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules. [PMID:38561350] | ["Ma B", "Khan K", "Xu T", "Xeque Amada | Journal of the American Chemic | 2024 | 0 |